Skip to Content

CeCors Inc CEOS

Morningstar Rating
$0.03 0.00 (13.25%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CEOS is trading within a range we consider fairly valued.
Price
$0.03
Fair Value
$7.34
Uncertainty
Extreme
1-Star Price
$2.46
5-Star Price
$9.50
Economic Moat
Zdn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CEOS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.03
Day Range
$0.030.03
52-Week Range
$0.010.05
Bid/Ask
$0.00 / $0.05
Market Cap
$9.96 Mil
Volume/Avg
55,806 / 371,094

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CeCors Inc along with its subsidiaries is engaged in the research and development, production, and commercialization of therapeutic and medicinal entheogenic, adaptogenic, and nootropic ingredients and formulations for its premium functional product lines which are developed by its mycology and botany experts. The company is also engaged in the scientific development of patentable technologies pertaining to the composition, bioavailability, and targeted delivery of entheogen-based therapeutics.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Total Number of Employees
6

Valuation

Metric
CEOS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CEOS
Quick Ratio
0.17
Current Ratio
0.33
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
CEOS
Return on Assets (Normalized)
−330.44%
Return on Equity (Normalized)
−1,247.35%
Return on Invested Capital (Normalized)
−521.60%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
MrcyjsjjrXrg$163.9 Bil
Becton Dickinson & Co
BDX
PskjkzcMrjhvh$66.8 Bil
Alcon Inc
ALC
SzclzhppNfnpb$44.6 Bil
ResMed Inc
RMD
LvkcrbkcmMpxqslj$30.5 Bil
Coloplast A/S ADR
CLPBY
XgvmrcqwgKtr$28.9 Bil
West Pharmaceutical Services Inc
WST
MhjfrdrbfMjcv$23.3 Bil
Hologic Inc
HOLX
BsgtzspdWjlcvc$18.3 Bil
The Cooper Companies Inc
COO
LzpbcjstSltvdx$18.2 Bil
Baxter International Inc
BAX
VqmkqkrQjzknl$18.0 Bil
Teleflex Inc
TFX
KtrpZlq$10.5 Bil

Sponsor Center